HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pheochromocytoma: 20 years of improving surgical care.

AbstractBACKGROUND:
Laparoscopic adrenalectomy is now the standard for pheochromocytoma. We report two decades of institutional experience with pheochromocytoma adrenalectomy.
METHODS:
A retrospective review was undertaken of pheochromocytoma adrenalectomy patients between 1997 and 2017. Clinical variables and postoperative complications were recorded. Patients were divided into quartiles for analysis: group 1 from 1997 to 2001, group 2 from 2002 to 2006, group 3 from 2007 to 2011, and group 4 from 2012 to 2017.
RESULTS:
Eighty-two pheochromocytoma adrenalectomies were identified. The percentage of laparoscopic adrenalectomies increased over time: 60% in group 1-87.5% in group 4 (p = 0.03). The average tumor size decreased: 6.4 cm (2.8-14.3 cm) in group 1-4.6 cm (1.2-7.8 cm) in group 4 (p = 0.03). ICU utilization decreased from 80% to 40.6% (p = 0.03) and length of stay decreased from 7.2 days to 2.7 days (p = 0.005). Clavien-Dindo grade>3 complications did not differ between the quartiles (p = 0.08).
CONCLUSION:
Pheochromocytoma care has evolved from more open procedures with standard postoperative ICU stay to a laparoscopic resection with targeted ICU care and decreased length of stay. As experience with laparoscopic adrenalectomy increases, patient outcomes improve.
AuthorsTarin C Worrest, Erin W Gilbert, Brett C Sheppard
JournalAmerican journal of surgery (Am J Surg) Vol. 217 Issue 5 Pg. 967-969 (05 2019) ISSN: 1879-1883 [Electronic] United States
PMID30922520 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Topics
  • Adrenal Gland Neoplasms (pathology, surgery)
  • Adrenalectomy
  • Adult
  • Aged
  • Female
  • Humans
  • Intensive Care Units (trends)
  • Laparoscopy (trends)
  • Length of Stay (trends)
  • Male
  • Middle Aged
  • Pheochromocytoma (pathology, surgery)
  • Postoperative Complications
  • Quality Improvement
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: